GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+56.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$303M
AUM Growth
+$303M
(+34%)
Cap. Flow
-$50.7M
Cap. Flow
% of AUM
-16.7%
Top 10 Holdings %
Top 10 Hldgs %
52.23%
Holding
56
New
9
Increased
10
Reduced
15
Closed
12
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
$8M |
| 2 |
TG Therapeutics
TGTX
|
$7.79M |
| 3 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$6.47M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$6.31M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$6.15M |
Top Sells
| 1 |
Mersana Therapeutics
MRSN
|
$32.2M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$16.8M |
| 3 |
Ascendis Pharma
ASND
|
$12.6M |
| 4 |
Axsome Therapeutics
AXSM
|
$9.46M |
| 5 |
Adverum Biotechnologies
ADVM
|
$8.47M |
Sector Composition
| 1 | Healthcare | 88.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | 0 | – | – |
|
|
ORTX
52
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| – | – | -178,109 | Closed | -$1.34M |
|
|
AGTC
53
DELISTED
Applied Genetic Technologies Corporation
AGTC
| – | – | -372,806 | Closed | -$1.22M |
|
|
PHAS
54
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| – | – | -497,074 | Closed | -$1.65M |
|
|
KDMN
55
DELISTED
Kadmon Holdings, Inc.
KDMN
| – | – | -350,000 | Closed | -$1.47M |
|
|
ZGNX
56
DELISTED
Zogenix, Inc.
ZGNX
| – | – | -150,000 | Closed | -$3.71M |
|